• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

雌性大鼠对B族链球菌III型免疫的调理抗体反应:母源性免疫模型

The opsonic antibody response of female rats to type III group B streptococcal immunization: a model for maternal immunity.

作者信息

Heiman H S, Weisman L E

机构信息

Department of Pediatrics, Uniformed Services University, Bethesda, MD 20814-4799.

出版信息

Vet Immunol Immunopathol. 1990 Jan;24(1):79-89. doi: 10.1016/0165-2427(90)90079-8.

DOI:10.1016/0165-2427(90)90079-8
PMID:2180204
Abstract

Group B streptococcus (GBS) remains a major cause of neonatal infection. Maternal immunization-induced GBS antibody may protect neonates from GBS disease. Since the opsonophagocytosis assay correlates well with survival in GBS infected suckling rats, we sought to determine an immunization schedule which would induce type III GBS opsonic antibody in rat dams above a predetermined level of 10 dilution-1 (dil-1). This schedule could then be used for future studies of maternal-fetal immunity. Wistar rat dams (n = 12) were given killed GBS type III using three immunization schedules (primary injection, initial booster at 7, 14 or 22 days and then weekly boosters). Opsonic GBS type III antibody and total immunoglobulin (IgG) were measured. Only the schedule with a 7-day initial booster resulted in GBS type-specific opsonic antibody consistently above 10 dil-1. The IgG (467 +/- 83 mg/100 ml) remained constant while the opsonic antibody increased significantly to 50 and 63 dil-1 (P less than 0.01 compared to day 0) after boosters on day 7 and 14 respectively. Eight pregnant dams, who received a primary immunization and boosters at 7 and 14 days, developed GBS type III opsonic antibody titers (72 dil-1) similar to non-pregnant dams and potentially adequate to protect suckling rats from GBS disease. This model may now be used to study other adjuvants, immunogens, and maternal-fetal immunity using established suckling rat models of GBS disease.

摘要

B族链球菌(GBS)仍然是新生儿感染的主要原因。母体免疫诱导产生的GBS抗体可能会保护新生儿免受GBS疾病的侵害。由于吞噬调理作用试验与GBS感染的乳鼠存活率密切相关,我们试图确定一种免疫方案,该方案能使大鼠母体内III型GBS调理抗体诱导至预定水平10倍稀释度-1(dil-1)以上。然后该方案可用于未来母婴免疫的研究。将12只Wistar大鼠母鼠分为三组,采用三种免疫方案(初次注射,分别在第7、14或22天进行初次加强免疫,之后每周进行一次加强免疫)给予灭活的III型GBS。检测III型GBS调理抗体和总免疫球蛋白(IgG)。只有初次加强免疫在第7天的方案能使GBS型特异性调理抗体持续高于10 dil-1。IgG(467±83 mg/100 ml)保持恒定,而调理抗体在第7天和第14天加强免疫后分别显著增加至50和63 dil-1(与第0天相比,P<0.01)。8只在第0天进行初次免疫,并在第7天和第14天进行加强免疫的怀孕母鼠,其III型GBS调理抗体滴度(72 dil-1)与未怀孕母鼠相似,可能足以保护乳鼠免受GBS疾病的侵害。现在可以使用这个模型,利用已建立的GBS疾病乳鼠模型来研究其他佐剂、免疫原和母婴免疫。

相似文献

1
The opsonic antibody response of female rats to type III group B streptococcal immunization: a model for maternal immunity.雌性大鼠对B族链球菌III型免疫的调理抗体反应:母源性免疫模型
Vet Immunol Immunopathol. 1990 Jan;24(1):79-89. doi: 10.1016/0165-2427(90)90079-8.
2
Transplacental or enteral transfer of maternal immunization-induced antibody protects suckling rats from type III group B streptococcal infection.
Pediatr Res. 1989 Dec;26(6):629-32. doi: 10.1203/00006450-198912000-00023.
3
Type III group B streptococcal strain differences in susceptibility to opsonization with human serum.B族链球菌III型菌株对人血清调理作用的敏感性差异
Pediatr Res. 1981 Dec;15(12):1525-9. doi: 10.1203/00006450-198112000-00015.
4
Neonatal protection and preterm birth reduction following maternal group B streptococcus vaccination in a mouse model.小鼠模型中母体B族链球菌疫苗接种后的新生儿保护及早产减少情况
J Matern Fetal Neonatal Med. 2017 Dec;30(23):2844-2850. doi: 10.1080/14767058.2016.1265932. Epub 2016 Dec 14.
5
Level of maternal IgG anti-group B streptococcus type III antibody correlated with protection of neonates against early-onset disease caused by this pathogen.母亲抗Ⅲ型B族链球菌IgG抗体水平与新生儿抵御该病原体引起的早发型疾病的保护作用相关。
J Infect Dis. 2004 Sep 1;190(5):928-34. doi: 10.1086/422756. Epub 2004 Jul 28.
6
Immunoglobulin therapy of neonatal group B streptococcal infections: an overview.新生儿B族链球菌感染的免疫球蛋白治疗:综述
Pediatr Infect Dis J. 1988 May;7(5 Suppl):S13-6.
7
Immune response to type III group B streptococcal polysaccharide-tetanus toxoid conjugate vaccine.对III型B族链球菌多糖-破伤风类毒素结合疫苗的免疫反应。
J Clin Invest. 1996 Nov 15;98(10):2308-14. doi: 10.1172/JCI119042.
8
Immunogenicity and protective activity in animals of a type V group B streptococcal polysaccharide-tetanus toxoid conjugate vaccine.V 型 B 族链球菌多糖-破伤风类毒素结合疫苗在动物体内的免疫原性和保护活性
J Infect Dis. 1995 Apr;171(4):879-84. doi: 10.1093/infdis/171.4.879.
9
Safety and immunogenicity of an investigational maternal trivalent group B streptococcus vaccine in healthy women and their infants: a randomised phase 1b/2 trial.一种研究性的母体 B 群链球菌三联疫苗在健康女性及其婴儿中的安全性和免疫原性:一项随机 1b/2 期试验。
Lancet Infect Dis. 2016 Aug;16(8):923-34. doi: 10.1016/S1473-3099(16)00152-3. Epub 2016 Apr 29.
10
Human immunoglobulins for intravenous use: comparison of available preparations for group B streptococcal antibody levels, opsonic activity, and efficacy in animal models.静脉注射用人免疫球蛋白:对现有制剂中B族链球菌抗体水平、调理活性及在动物模型中的疗效进行比较。
Pediatrics. 1990 Dec;86(6):955-62.

引用本文的文献

1
Maternal vaccination: moving the science forward.孕产妇疫苗接种:推动科学进步。
Hum Reprod Update. 2015 Jan-Feb;21(1):119-35. doi: 10.1093/humupd/dmu041. Epub 2014 Jul 11.